Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. (2023)
Attributed to:
Controlling COVID19 through enhanced population surveillance and intervention (Con-COV): a platform approach
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ije/dyac199
PubMed Identifier: 36272418
Publication URI: http://europepmc.org/abstract/MED/36272418
Type: Journal Article/Review
Volume: 52
Parent Publication: International journal of epidemiology
Issue: 1
ISSN: 0300-5771